Inventa Biotech Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Out of Business

  • Employees
  • 24

Employees

  • Latest Deal Type
  • PIPE

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 1

Inventa Biotech General Information

Description

Developer of an automated patch clamp platform designed to mimic a manual patch rig. The company's automated patch clamp platform uses artificial intelligence and offers cell capture and sealing with quartz glass electrodes, seal resistance without the need for seal enhancers, recordings at physiologic temperatures and perfusion of the well for multiple concentration exposures, enabling researchers to achieve their screening goals quickly and efficiently with significant time and cost reductions.

Contact Information

Formerly Known As
Cytocentrics, CytoBioscience, WestMountain Co, Cytocentrics, Inc., Cytbioscience, Inc.
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 3463 Magic Drive
  • Suite 120
  • San Antonio, TX 78229
  • United States
+1 (800)
Primary Industry
Biotechnology
Other Industries
Automation/Workflow Software
Drug Delivery
Corporate Office
  • 3463 Magic Drive
  • Suite 120
  • San Antonio, TX 78229
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inventa Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. PIPE 19-Mar-2018 $1.5M Completed Generating Revenue
6. Reverse Merger 19-Mar-2018 Completed Generating Revenue
5. Merger/Acquisition 08-Nov-2017 Cancelled Generating Revenue
4. Later Stage VC (Series A) 10-Aug-2016 Completed Generating Revenue
3. Grant 12-Jun-2015 Completed Generating Revenue
2. Early Stage VC $50K Completed Generating Revenue
1. Accelerator/Incubator $50K $50K Completed Generating Revenue
To view Inventa Biotech’s complete valuation and funding history, request access »

Inventa Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Inventa Biotech’s complete cap table history, request access »

Inventa Biotech Patents

Inventa Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180255766-A1 Portable physiological transport unit Inactive 10-Mar-2017

Inventa Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inventa Biotech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
WestMountain Co Corporation Minority
To view Inventa Biotech’s complete investors history, request access »

Inventa Biotech Acquisitions (3)

Inventa Biotech’s most recent deal was a Merger/Acquisition with BioDTech for . The deal was made on 28-Nov-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BioDTech 28-Nov-2018 Merger/Acquisition Specialty Chemicals
WestMountain Co 19-Mar-2018 Merger/Acquisition Asset Management
Soluble Biotech 01-Nov-2016 Merger/Acquisition Drug Discovery
To view Inventa Biotech’s complete acquisitions history, request access »

Inventa Biotech Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
WestMountain Co Fort Collins, CO 2007

Inventa Biotech FAQs

  • When was Inventa Biotech founded?

    Inventa Biotech was founded in 2001.

  • Where is Inventa Biotech headquartered?

    Inventa Biotech is headquartered in San Antonio, TX.

  • What is the size of Inventa Biotech?

    Inventa Biotech has 24 total employees.

  • What industry is Inventa Biotech in?

    Inventa Biotech’s primary industry is Biotechnology.

  • Is Inventa Biotech a private or public company?

    Inventa Biotech is a Private company.

  • What is Inventa Biotech’s current revenue?

    The current revenue for Inventa Biotech is .

  • How much funding has Inventa Biotech raised over time?

    Inventa Biotech has raised $17.4M.

  • Who are Inventa Biotech’s investors?

    WestMountain Co has invested in Inventa Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process